Drugmaker Eli Lilly said Tuesday it will sell single-use vials of its weight-loss drug Zepbound at a fraction of the price of its pens, amid skyrocketing demand among Americans for anti-obesity ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Eli Lilly has released a new vial version of its blockbuster weight-loss drug Zepbound for about half the ...
We are aware of reports regarding supply issues of insulin in the UK. Here’s the latest information on how your treatment may be impacted.
Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced Tuesday, a move the company says will “significantly” expand ...
Aug 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Tuesday it has begun selling vials of the lowest starter dose of its popular weight-loss drug Zepbound in the United States for $399 for ...
Eli Lilly & Co. is now selling vials of its blockbuster weight-loss drug Zepbound to patients for as little as $399 a month as it works to overcome supply shortages of wildly popular shots.
Eli Lilly & Co. LLY said Tuesday that patients can now access 2.5- and 5-milligram single-dose vials of its weight-loss treatment Zepbound with an on-label prescription at a discount of at least ...
Eli Lilly is launching singe-use vials of its popular weight-loss drug Zepbound, which will be half the price of previous versions of the drug. The traditional injector pens are more difficult to ...
Lilly said it has introduced single-dose vials of its obesity medication, Zepbound, priced at a 50% discount compared to other incretin medicines. This move comes amid growing competition in the ...
INDIANAPOLIS — Eli Lilly is releasing single-dose vials of weight loss drug Zepbound that will help adults living with obesity. Zepbound 2.5 mg and 5 mg single-dose vials are available for patients ...
Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says it will now offer the medication in single-dose vials at half the price currently available to consumers.